The National Institutes of Health announced plans to test at least four different treatments for long COVID, including Pfizer’s Paxlovid, as potential therapies for the lasting condition, according to a July 31 news release.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,